This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
After nearly two and a half years in print, BioCommerce Week is overhauling its coverage area, adding several well-known players in the molecular biology tools industry that were previously not considered core to coverage.
Registering provides access to this and other free content.
Already have an account?Login Now.
CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.
Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.
Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.
In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.